SPLICING OF MAMU AG MRNA SUGGESTS EXISTENCE OF SOLUBLE MHC CLASS I MOLECULE
MAMU AG mRNA 的剪接表明可溶性 MHC I 类分子的存在
基本信息
- 批准号:6116422
- 负责人:
- 金额:$ 6.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-05-01 至 2000-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
OBJECTIVE To determine whether mRNAs are expressed in the rhesus
placenta which could encode a soluble MHC class I molecule. RESULTS
An unusual feature of both the human placental MHC class I molecule
HLA-G and the rhesus molecule Mamu-AG is expression of multiple
protein isoforms and splice variants. Splice variants also exist for
HLA-G which encode a soluble protein but the presence of a mRNA
encoding a soluble rhesus MHC class I molecule has not previously been
detected. We cloned a fragment of the Mamu-AG gene from rhesus monkey
genomic DNA to define the sequences of intron 4 and 5 and noted that
the sequence of intron 4 was highly homologous to that of HLA-G (88%
identical), which is similar to exon 4 homology with HLA-A sequences
(~91%), but higher than that for intron 5, suggesting that
evolutionary drift of intron 4 has been restrained and implying
selection for functionally important sequences. We then conducted
RT-PCR analyses with placental mRNA using an upstream primer specific
for Mamu-AG exon 4, and a downstream primer which would amplify
through the 3U-untranslated region and allow diagnostic identification
of Mamu-AG transcripts via the premature stop codon homologous to
HLA-G. RT-PCR products were amplified from placental RNA, cloned and
sequenced. A stop codon (TAG) is present in the exact codon location
of the TAA stop codon in the soluble HLA-G reading frame of intron 4.
The predicted amino acid sequences of the carboxy-terminal end of the
4th exon and the intron 4 peptides indicate identity with the human
sequence at 16/21 residues, and conservative substitutions (e.g., G to
S) at the other 5 residues. Further studies cloned and defined the
sequences of the other introns of Mamu-AG. FUTURE DIRECTIONS These
results suggest that the rhesus monkey will be a model for addressing
the physiology of soluble Mamu-AG. We will evaluate 1) the expression
of soluble mRNA in the fetal membranes, 2) whether antibodies against
soluble HLA-G recognize the rhesus molecule, and 3) rhesus amniotic
fluid and fetal serum for the presence of soluble MHC class I
molecules. KEY WORDS maternal-fetal immune tolerance, placenta,
amniotic fluid, splice variant FUNDING NIH HD 26458, HD34216
目的研究恒河猴体内是否存在mRNAs表达。
胎盘可以编码一种可溶性的MHC-I类分子。结果
人类胎盘MHC I类分子的一个不同寻常的特征
人类白细胞抗原-G和恒河猴分子MAMU-AG是多重表达的
蛋白质异构体和剪接变体。拼接变体也存在于
人类白细胞抗原G编码一种可溶性蛋白,但存在一种
编码可溶性恒河猴MHC I类分子以前从未被
检测到。我们克隆了恒河猴MAMU-AG基因的一个片段
基因组DNA来定义内含子4和5的序列,并注意到
内含子4的序列与人类白细胞抗原G基因高度同源(88%
相同),与外显子4相似,与人类白细胞抗原-A序列同源
(~91%),但高于内含子5,表明
内含子4的进化漂移受到抑制并暗示
功能重要序列的选择。然后我们进行了
用上游特异性引物RT-PCR分析胎盘组织中的mRNA
针对MAMU-AG外显子4,以及可扩增出
通过3U-非翻译区并允许诊断识别
通过与MAMU-AG同源的提前终止密码子
人类白细胞抗原G。从胎盘RNA中扩增RT-PCR产物,克隆和
已排序。终止密码子(标签)存在于准确的密码子位置
TAA终止密码子位于内含子4可溶的人类白细胞抗原-G阅读框中。
预测的氨基酸序列的羧基末端
第4外显子和第4内含子多肽表明与人类相同
16/21残基的序列和保守的替换(例如,G到
S)在其他5个残基上。进一步的研究克隆和定义了
MAMU-AG其他内含子的序列。这些是未来的方向
结果表明,恒河猴将是解决
可溶性MAMU-AG的生理特性。我们将对1)表达式求值
胎膜中可溶性mRNA的表达,2)抗体是否针对
可溶性人类白细胞抗原-G识别恒河猴分子;3)恒河猴羊水
体液和胎儿血清中可溶性MHC-I类的检测
分子。关键词母胎免疫耐受、胎盘、
羊水,剪接变异资助,美国国立卫生研究院HD 26458,HD34216
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THADDEUS G GOLOS其他文献
THADDEUS G GOLOS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THADDEUS G GOLOS', 18)}}的其他基金
Targeted Delivery of Liposomes to the Primate Maternal-Fetal Interface
将脂质体靶向递送至灵长类母胎界面
- 批准号:
9979328 - 财政年份:2020
- 资助金额:
$ 6.42万 - 项目类别:
Magnetic resonance imaging of the antecedents of fetal growth restriction at the primate maternal-fetal interface
灵长类母胎界面胎儿生长受限前因的磁共振成像
- 批准号:
10237390 - 财政年份:2020
- 资助金额:
$ 6.42万 - 项目类别:
Magnetic resonance imaging of the antecedents of fetal growth restriction at the primate maternal-fetal interface
灵长类母胎界面胎儿生长受限前因的磁共振成像
- 批准号:
10404011 - 财政年份:2020
- 资助金额:
$ 6.42万 - 项目类别:
Magnetic resonance imaging of the antecedents of fetal growth restriction at the primate maternal-fetal interface
灵长类母胎界面胎儿生长受限前因的磁共振成像
- 批准号:
10074849 - 财政年份:2020
- 资助金额:
$ 6.42万 - 项目类别:
Project 1: Impact of sustained ZIKV viremia in pregnancy
项目 1:妊娠期持续 ZIKV 病毒血症的影响
- 批准号:
10220702 - 财政年份:2018
- 资助金额:
$ 6.42万 - 项目类别:
Pathways of vertical Zika virus transmission in nonhuman primate pregnancy
非人灵长类动物怀孕期间寨卡病毒垂直传播的途径
- 批准号:
9894729 - 财政年份:2018
- 资助金额:
$ 6.42万 - 项目类别:
Nonhuman Primate Model to Assess Fetal Zika Virus Infection Complications
用于评估胎儿寨卡病毒感染并发症的非人类灵长类动物模型
- 批准号:
9262695 - 财政年份:2017
- 资助金额:
$ 6.42万 - 项目类别:
CCR5-mutant monkey model to facilitate the development of novel stem cell-based therapies for AIDS
CCR5突变猴模型促进新型干细胞艾滋病疗法的开发
- 批准号:
9264608 - 财政年份:2016
- 资助金额:
$ 6.42万 - 项目类别:
CCR5-mutant monkey model to facilitate the development of novel stem cell-based therapies for AIDS
CCR5突变猴模型促进新型干细胞艾滋病疗法的开发
- 批准号:
9490509 - 财政年份:2016
- 资助金额:
$ 6.42万 - 项目类别:
CCR5-mutant monkey model to facilitate the development of novel stem cell-based therapies for AIDS
CCR5突变猴模型促进新型干细胞艾滋病疗法的开发
- 批准号:
9140295 - 财政年份:2016
- 资助金额:
$ 6.42万 - 项目类别:
相似海外基金
Pioneering reproductive biotechnology innovations for equine breeding
开创马匹育种生殖生物技术创新
- 批准号:
LP230100156 - 财政年份:2024
- 资助金额:
$ 6.42万 - 项目类别:
Linkage Projects
Industrial Biotechnology Innovation Cluster
产业生物技术创新集群
- 批准号:
EP/Y024168/1 - 财政年份:2024
- 资助金额:
$ 6.42万 - 项目类别:
Research Grant
Environmental Biotechnology Innovation Centre
环境生物技术创新中心
- 批准号:
BB/Y008332/1 - 财政年份:2024
- 资助金额:
$ 6.42万 - 项目类别:
Research Grant
MFB: Partnerships to Transform Emerging Industries - RNA Tools/Biotechnology: Stabilizing Hairpin Inserts in RNA Virus Induced Gene Silencing Vectors
MFB:合作变革新兴产业 - RNA 工具/生物技术:稳定 RNA 病毒诱导基因沉默载体中的发夹插入
- 批准号:
2330663 - 财政年份:2024
- 资助金额:
$ 6.42万 - 项目类别:
Standard Grant
Conference: Translating Molecular Science Innovations into Biotechnology Solutions
会议:将分子科学创新转化为生物技术解决方案
- 批准号:
2419731 - 财政年份:2024
- 资助金额:
$ 6.42万 - 项目类别:
Standard Grant
Shear Innovation: Valorising wool waste using biotechnology to enhance horticultural peat-free growing media
剪切创新:利用生物技术提高羊毛废料的价值,以增强园艺无泥炭生长介质
- 批准号:
10106787 - 财政年份:2024
- 资助金额:
$ 6.42万 - 项目类别:
Launchpad
NSF Convergence Accelerator Track M: Biofilm-based Corrosion Control using 3D Printed Biotechnology
NSF 融合加速器轨道 M:使用 3D 打印生物技术进行基于生物膜的腐蚀控制
- 批准号:
2344389 - 财政年份:2024
- 资助金额:
$ 6.42万 - 项目类别:
Standard Grant
I-Corps: Translation potential of a miniaturized biotechnology platform for nucleic acid extraction, purification, and library preparation
I-Corps:用于核酸提取、纯化和文库制备的小型生物技术平台的转化潜力
- 批准号:
2421022 - 财政年份:2024
- 资助金额:
$ 6.42万 - 项目类别:
Standard Grant
Engineering Biology Hub for environmental processing and recovery of metals; from contaminated land to industrial biotechnology in a circular economy
用于环境处理和金属回收的工程生物中心;
- 批准号:
BB/Y008456/1 - 财政年份:2024
- 资助金额:
$ 6.42万 - 项目类别:
Research Grant
Development of magnetic force biotechnology to facilitate neural regeneration
开发磁力生物技术促进神经再生
- 批准号:
EP/X014126/1 - 财政年份:2023
- 资助金额:
$ 6.42万 - 项目类别:
Research Grant